Even when healing is achieved, recurrence rates approach 40% within 1 year, highlighting the urgent need for more effective therapeutic strategies that target the underlying molecular mechanisms
Researchers are paying special attention to changes in liver enzymes, heart rate, and blood glucose in trial participants
The resulting 2,500 mcg/mL concentration maps cleanly to round numbers on a U-100 syringe, reducing the chance of dosing errors
Semaglutide: Semaglutide acts primarily as a GLP-1 (glucagon-like peptide-1) receptor agonist
Matsuo Y, Ishihara T, Ishizaki J, Miyamoto K, Higaki M, Yamashita N
Data availability Requests for data and materials should be addressed to the corresponding author